Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 104

Sort by

Sort Order Select

Journal Articles

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias

Jason Moran, Kenneth A. Bauer

Blood (2020) 135 (5): 344–350.

https://doi.org/10.1182/blood.2019000917

Published: 2020

Journal Articles

Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism

Rachel P Rosovsky, MDMPH, Islam Y Elgendy, MD, Suzanne C Cannegieter, MD PhD, Menno V Huisman, MD PhD, David Jimenez, MD PhD, Jorge del Toro, MD, Vladimir Rosa, MD PhD, Carmen Fernández-Capitán, MD PhD, Alessandra Bura-Riviere, MD PhD, Manuel Monreal, MD PhD

Blood (2019) 134 (Supplement_1): 2429.

https://doi.org/10.1182/blood-2019-131090

Published: 2019

Journal Articles

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Effrosyni Apostolidou, MD, PhD, Masumeh Hatami, MD, Sean.I. Savitz, MD, Eric Thomas, MD, Priya Khatri, MBA, MPH, Alicia Zha, MD

Blood (2019) 134 (Supplement_1): 3397.

https://doi.org/10.1182/blood-2019-124521

Published: 2019

Journal Articles

Provider Practices Regarding Prophylactic Anticoagulation in Children with Leukemia

Nicole Kucine, MD, Melanie Degliuomini, MD, Elizabeth Mauer, MS, Victoria Cooley, MS, Linda M Gerber, PhD, Suchitra Acharya, MD

Blood (2019) 134 (Supplement_1): 3412.

https://doi.org/10.1182/blood-2019-123084

Published: 2019

Journal Articles

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

Ivan Bascon, Molecular Bioscience and Biotechnology, B.S., Paul J Christos, Dr.P.H., M.S., Maria Teresa De Sancho, MD MSc

Blood (2019) 134 (Supplement_1): 3657.

https://doi.org/10.1182/blood-2019-132248

Published: 2019

Journal Articles

An Institutional Survey of Thrombophilia Evaluation in the Setting of Venous Thromboembolism (VTE)

Ian Garrahy, DO, Tushar Pawar, MD MPH, Anthony Donato, MD, Amber Stevenson, CMA, Daniel Forman, DO

Blood (2019) 134 (Supplement_1): 4956.

https://doi.org/10.1182/blood-2019-128908

Published: 2019

Journal Articles

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

Milagros Suito, MD, Maria Cerdá, MD, Olga Benítez, MD, Alba Cabirta, MD, Francesc Bosch, MD PhD, Amparo Santamaria, MD PhD

Blood (2019) 134 (Supplement_1): 4958.

https://doi.org/10.1182/blood-2019-132042

Published: 2019

Journal Articles

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

Leila Khaddour, MD, Zaid Al Saheli, MD, Yaser Alkhatib, MD, Marwan Abouljoud, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 2442.

https://doi.org/10.1182/blood-2019-124169

Published: 2019

Journal Articles

In Vivo hemostatic Significance of Activated Protein C in Factor VIIIa Regulation

Amelia R. Wilhelm, B.S., Nicole A. Parsons, B.S., Charles T. Esmon, PhD, Rodney M. Camire, PhD, Lindsey A. George, MD

Blood (2019) 134 (Supplement_1): 93.

https://doi.org/10.1182/blood-2019-124493

Published: 2019

Journal Articles

Effectiveness of Standard-Dose Thromboprophylaxis with Enoxaparin in Preventing Recurrent Venous Thromboembolism in Pregnancy

Marie Claire McLintock, MD, Renee Eslick, MBBS, Stephanie Cox

Blood (2018) 132 (Supplement 1): 3802.

https://doi.org/10.1182/blood-2018-99-119405

Published: 2018

Journal Articles

Risk Factors for Pregnancy-Associated Venous Thromboembolism: The Role of Maternal Age, Obesity, Smoking and Other Modifiable Risk Factors

Rahil Kohli, Alison R. Moliterno, MD, Michael B. Streiff, MD, Michael R. DeBaun, MD, Thomas S. Kickler, MD, Karin Blakemore, Shruti Chaturvedi, MBBS, MS

Blood (2018) 132 (Supplement 1): 3804.

https://doi.org/10.1182/blood-2018-99-113599

Published: 2018

Journal Articles

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Livingstone Gayus Dogara, MBBS, FMCPath, Joseph Ogirima Ovosi, MBBS, MSc, FMCP (Clinical Pharmacology), Caleb Mohammed, MBBS, FWACS, Bilkisu Farouk, MBBS, FWACS, Ziphozonke Mafika, MBBCH, MMed, FCPath, Johnny Mahlangu

Blood (2018) 132 (Supplement 1): 5056.

https://doi.org/10.1182/blood-2018-99-114865

Published: 2018

Journal Articles

Longer Duration and Proper Titration of Low Molecular Weight Heparin (LMWH), Are Independent Factors for Successful Pregnancy Outcome. Retrospective Analysis from a Single Center

Maria Stamou, Jr., Stergios Intzes, Jr., Eleftheria Lamprianidou, Menelaos Konstantinos Papoutselis, Zoe Bezirgiannidou, Evangelia Nakou, Zafeirios Kartasis, MD, Georgios Vrachiolias, Ioanna Bazntiara, Ioannis Kotsianidis, PhD, Emmanouil Spanoudakis

Blood (2018) 132 (Supplement 1): 5065.

https://doi.org/10.1182/blood-2018-99-113980

Published: 2018

Journal Articles

The Utility of Hereditary Thrombophilia Testing Among Hospitalized Patients: A Single Center Experience

Omar Abughanimeh, MD, Mohammad Tahboub, MD, Anahat Kaur, MD, Mouhanna Abu Ghanimeh, MD, Zhang Zhiheng, An-lin Cheng, PhD, Timothy Pluard, MD

Blood (2018) 132 (Supplement 1): 2231.

https://doi.org/10.1182/blood-2018-99-114082

Published: 2018

Journal Articles

Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis

Thita Chiasakul, MD MSc, Elizabeth De Jesus, Jiayi Tong, B.S., Yong Chen, PhD, Mark Crowther, MD, David A. Garcia, MD, Chatree Chai-Adisaksopha, MD, Steven R. Messé, MD, Adam Cuker, MD MS

Blood (2018) 132 (Supplement 1): 2518.

https://doi.org/10.1182/blood-2018-99-110997

Published: 2018

Journal Articles

Thrombotic Risk Factors, Antithrombotic Therapy, and Outcomes of Asymptomatic Carriers of Antiphospholipid Antibodies and Patients with Antiphospholipid Syndrome

Ghaith Abu-Zeinah, MD, Clara Oromendia, MS, Maria Teresa De Sancho, MD

Blood (2017) 130 (Supplement 1): 3710.

https://doi.org/10.1182/blood.V130.Suppl_1.3710.3710

Published: 2017

Journal Articles

Use of Direct Oral Anticoagulants in Inherited Thrombophilia

Puja Arora, MD, Surabhi Palkimas, PharmD, Margaret Kim, Laura Talamo, MD, Hillary S. Maitland, MDMS

Blood (2017) 130 (Supplement 1): 3724.

https://doi.org/10.1182/blood.V130.Suppl_1.3724.3724

Published: 2017

Journal Articles

Regulation of Factor VIII By Activated Protein C: Assessment In Vitro and In Vivo

Nicole A. Parsons, B.S., Michelle D. Ho, BS, Robert J. Davidson, BS, Nabil K. Thalji, PhDMD, Ben J. Samelson-Jones, MD PhD, Rodney M Camire, PhD, Lindsey A. George, MD

Blood (2017) 130 (Supplement 1): 3650.

https://doi.org/10.1182/blood.V130.Suppl_1.3650.3650

Published: 2017

Journal Articles

Referral for Thrombophilia Testing in an Obstetric Patient Population: A Tertiary Centre Experience

Ayesha Ejaz, Helen Moore

Blood (2017) 130 (Supplement 1): 5597.

https://doi.org/10.1182/blood.V130.Suppl_1.5597.5597

Published: 2017

Journal Articles

Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001

Uma H. Athale, MD, M.Sc., Traci M. Blonquist, MS, Kristen E. Stevenson, MS, Menachem Spira, Peter D. Cole, MD, Barbara L Asselin, MD, Luis A. Clavell, MD, Kara M. Kelly, MD, Caroline Laverdière, MDFRCPC, Jean-Marie Leclerc, MD, Bruno Michon, MD, Marshall A. Schorin, MD, Maria Luisa Sulis, MD, Jennifer J.G. Welch, MD, Marian H. Harris, MD PhD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2017) 130 (Supplement 1): 1278.

https://doi.org/10.1182/blood.V130.Suppl_1.1278.1278

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Managing thromboembolic risk in patients with hereditary and acquired thrombophilias

Sex Differences in Risk Factors, Clinical Presentation, Treatment and Outcomes of Patients Presenting with Acute Pulmonary Embolism

Assessment and Reduction of Unnecessary Thrombophilia Testing in Patients 18-60 Years with Acute Cryptogenic Ischemic Stroke

Provider Practices Regarding Prophylactic Anticoagulation in Children with Leukemia

Risk Factors, Clinical Manifestations, Treatment Duration and Outcomes in Carriers of Severe Inherited Thrombophilias

An Institutional Survey of Thrombophilia Evaluation in the Setting of Venous Thromboembolism (VTE)

Facing Deep Venous Thrombosis (DVT) in University Tertiary Hospital: Role of Conventional Thrombophilia Testing in Idiopathic DVT Treatment

One- Week Prophylaxis with Enoxaparin after Hospital Discharge Is Effective in Preventing Venous Thromboembolism in Living Liver Donors- Single Institution Retrospective Analysis

In Vivo hemostatic Significance of Activated Protein C in Factor VIIIa Regulation

Effectiveness of Standard-Dose Thromboprophylaxis with Enoxaparin in Preventing Recurrent Venous Thromboembolism in Pregnancy

Risk Factors for Pregnancy-Associated Venous Thromboembolism: The Role of Maternal Age, Obesity, Smoking and Other Modifiable Risk Factors

Compound Homozygous Factor V Leiden and Heterozygous Prothrombin Gene Mutation: The First Report in a Pregnant African with Extensive Thrombosis

Longer Duration and Proper Titration of Low Molecular Weight Heparin (LMWH), Are Independent Factors for Successful Pregnancy Outcome. Retrospective Analysis from a Single Center

The Utility of Hereditary Thrombophilia Testing Among Hospitalized Patients: A Single Center Experience

Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis

Thrombotic Risk Factors, Antithrombotic Therapy, and Outcomes of Asymptomatic Carriers of Antiphospholipid Antibodies and Patients with Antiphospholipid Syndrome

Use of Direct Oral Anticoagulants in Inherited Thrombophilia

Regulation of Factor VIII By Activated Protein C: Assessment In Vitro and In Vivo

Referral for Thrombophilia Testing in an Obstetric Patient Population: A Tertiary Centre Experience

Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only